St. Jude Medical's CEO Discusses Q2 2011 Results - Earnings Call Transcript - Seeking Alpha Print
Seeking Alpha
Moving on to the substantial progress we are making with our emerging Renal Denervation business. We continue to keep details of our technology confidential for competitive reasons, but as we have previously stated, we view the renal denervation market

...